Peel Hunt began coverage on shares of Luceco (LON:LUCE) in a report published on Wednesday morning, ThisIsMoney.Co.Uk reports. The firm issued an add rating and a GBX 120 ($1.57) target price on the stock.

Separately, Numis Securities restated a buy rating and issued a GBX 115 ($1.50) price target on shares of Alliance Pharma in a research note on Friday, May 24th.

LUCE stock opened at GBX 103.20 ($1.35) on Wednesday. Luceco has a 1-year low of GBX 32.10 ($0.42) and a 1-year high of GBX 133 ($1.74). The business has a fifty day simple moving average of GBX 117.57. The company has a quick ratio of 0.72, a current ratio of 1.29 and a debt-to-equity ratio of 88.35. The stock has a market capitalization of $165.95 million and a PE ratio of 114.67.

Luceco Company Profile

Luceco plc manufactures and distributes various light emitting diode (LED) lighting products and wiring accessories in the United Kingdom, Europe, the Middle East, the Americas, the Asia Pacific, and Africa. It operates through four segments: Wiring Accessories, Portable Power, LED Lighting, and Ross and Other.

See Also: Earnings Reports

Receive News & Ratings for Luceco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Luceco and related companies with MarketBeat.com's FREE daily email newsletter.